Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study

Table 2 Baseline morbidity of the thyroid cancer survivors (n = 5677) and non-thyroid cancer individuals (n = 23,962)

Variable	Cancer group (n = 5677)	Non-cancer group (n = 23,962)	P
Hypertension^a, n (%)	1405 (24.7)	4629 (19.3)	< 0.001
Diabetes mellitus^b, n (%)	707 (12.5)	2681 (11.2)	0.007
Dyslipidemia^c, n (%)	1865 (32.9)	6822 (28.5)	< 0.001
AF, n (%)	170 (0.3)	117 (0.5)	< 0.001
Rheumatic heart disease, n (%)	8 (0.1)	16 (0.1)	0.077
Fatty liver, n (%)	101 (1.8)	285 (1.2)	< 0.001
Cerebrovascular disease^*1, n (%)	53 (0.9)	624 (2.6)	< 0.001
Cardiovascular disease^*2, n (%)	119 (2.1)	1330 (5.6)	< 0.001
Cerebrovascular & cardiovascular diseases ^1 & ^2, n (%)	154 (2.7)	1.631 (6.8)	< 0.001

^aPhysician diagnosis of hypertension or at least three measurements of systolic blood pressure > 140 mmHg, or of diastolic blood pressure > 90 mmHg, or hypertension medications; ^bPhysician diagnosis of diabetes mellitus, or twice blood fasting glucose ≥126 mg/dL, or random blood glucose ≥200 mg/dL, or hypoglycemic medications; ^cPhysician diagnosis of hyperlipidemia, or at least two measurements of LDL > 160 mg/dL, or TG > 150 mg/dL, or HDL < 40 mg/dL for males, or HDL < 50 mg/dL for females, or hypolipidemic medications. AF, Atrial fibrillation; ^*1, Transient ischemic attack, cerebral vascular attack, carotid artery stenosis and occlusion, carotid endarterectomy; ^*2, Ischemic heart disease, acute myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft
Bold indicates significant

ISSN: 1471-2407